TRxADE HEALTH, Inc.
TRxADE HEALTH, Inc. (MEDS) Stock Overview
Explore TRxADE HEALTH, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
13.3M
P/E Ratio
-6.94
EPS (TTM)
$-24.38
ROE
-0.26%
MEDS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of TRxADE HEALTH, Inc. (MEDS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $2.73.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.94 and a market capitalization of 13.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.